Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mamta MavDesignation :- Company Secretary and Compliance Officer Aspira Pathlab & Diagnostics Ltd - 540788 - Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
With reference to the above, we write to inform you that the Code of Practices and procedures for fair Disclosure of unpublished price sensitive information formulated pursuant to Regulation 8 of SEBI (prohibition of Insider Trading) Regulation, 2015, has been amended in terms of SEBI (Prohibition of Insider Trading) (Amendment) Regulation, 2018, effective from April 01, 2019 and the amended code is hosted on the website at www.aspiradiagnostics.com Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
The financial results of the Company for the quarter and year ending March 31, 2019 will be declared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We write to inform you that in view of the foregoing and in accordance with the Code of Conduct for prevention of Insider trading framed by the Company, the Trading Window for Designated Persons will be closed for the period from April 01, 2019 till 48 hours after the declaration of financial results to Stock Exchange. Thanking you. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Director
This is to inform you that Dr. Chander Puri, Executive Director and CEO of the Company, has tendered his resignation from the position of Executive Director and CEO, with effect from close of business hours of March 31, 2019. Kindly take the above information on record. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Meeting Updates
The Independent Directors in its meeting held on January 21, 2019 transacted the following businesses; 1. To review the performance of non-independent directors and the board of directors as whole of the Company. 2. To review the performance of the Chairperson of the Company. 3. To assess the quality, quantity and timelines of flow of information between the Management of the Company and the Board of directors to effectively and reasonably perform their duties. Kindly note the same. Aspira Pathlab & Diagnostics Ltd - 540788 - Financial Results - December 31, 2018
We hereby inform you that the Board of Directors of the Company, at its meeting held today i.e. Monday, January 21, 2019 inter alia considered and approved the unaudited Standalone financial results of the Company for the quarter and nine months ended December 31, 2018 and the same are enclosed herewith along with Limited Review Reports given by the Statutory Auditors on the above financial results. Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome of Board Meeting
In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (read with Part A of schedule III), We hereby inform you that the Board of Directors of the Company, at its meeting held today i.e. Monday, January 21, 2019 inter alia considered and approved the unaudited Standalone financial results of the Company for the quarter and nine months ended December 31, 2018 and the same are enclosed herewith along with Limited Review Reports given by the Statutory Auditors on the above financial results. The meeting of the Board of Directors commenced at 3.15 pm and concluded at 5.45 pm. Kindly take the same on your records. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed Public Notice published in the Newspapers viz. - Business Standard (in English) and Lakshadeep (in Marathi) on January 13, 2019, informing about the Board Meeting of the Company scheduled to be held on Monday, January 21, 2019, inter alia, consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2018. Aspira Pathlab & Diagnostics Ltd - 540788 - Revision of Board Meeting
Purpose of the meeting has been revised